HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Intramuscular bipenicillin vs. intravenous penicillin in the treatment of erysipelas in adults: randomized controlled study.

Abstract
The objective of the study was to evaluate the efficacy of intramuscular penicillin: mixture of benzyl penicillin and procain penicillin (2 MU x 2 times daily) and intravenous benzyl penicillin (4 MU x 6 times daily) in the treatment of hospitalized adult patients with erysipelas. A prospective randomized unicentric trial was conducted. In total, 112 patients entered the study; 57 in the intramuscular group and 55 patients in the intravenous group completed the trial. The failure rate was 14% for intramuscular group and 20% for the intravenous group (P = 0.40). Local complications such as of the leg abscesses were observed in the two groups (intravenous 9.1%, intramuscular 7%; P = 0477). Of the patients treated with intravenous benzyl penicillin, 25.5% presented complications related to the route (venitis). Intramuscular penicillin should be considered an effective and well-tolerated treatment of erysipelas in adult patients.
AuthorsF Zeglaoui, C Dziri, I Mokhtar, N Ezzine, M Kharfi, M Zghal, B Fazaa, M R Kamoun
JournalJournal of the European Academy of Dermatology and Venereology : JEADV (J Eur Acad Dermatol Venereol) Vol. 18 Issue 4 Pg. 426-8 (Jul 2004) ISSN: 0926-9959 [Print] Netherlands
PMID15196155 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Bacterial Agents
  • Penicillin G Procaine
  • Penicillin G
Topics
  • Adult
  • Anti-Bacterial Agents (administration & dosage, adverse effects)
  • Drug Administration Schedule
  • Erysipelas (drug therapy)
  • Female
  • Humans
  • Injections, Intramuscular (adverse effects)
  • Injections, Intravenous (adverse effects)
  • Male
  • Penicillin G (administration & dosage, adverse effects)
  • Penicillin G Procaine (administration & dosage, adverse effects)
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: